Siteman Advantage

Fact: The Siteman Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center in Missouri and is ranked among the top cancer facilities in the nation by U.S. News & World Report.

What this means for you: They provide a full range of cancer diagnosis and treatment options led by specialists at the top of their field, many involved in leading-edge research on novel therapies.

Fact: Siteman has one of the largest centers in the Midwestern United States focused exclusively on the diagnosis and treatment of sarcoma. Although the prevalence of these tumors is less than one percent, the multidisciplinary team at Siteman sees hundreds of new patients a year and has a full array of treatments and clinical trials under way to treat these rare tumors.

What this means for you: The Sarcoma Center at Siteman is one of the most active in the United States and annually sees hundreds of patients for the evaluation and treatment of rare bone, muscle and connective tissue tumors. The breadth and depth of their expertise benefits each patient.

Fact: Siteman pioneered the development of genomic testing for personalized, targeted treatment. Treatment is targeted to the genetic components of the cancer.

What this means for you: Knowing the genetic make-up of your cancer yields important information about which treatments may be more effective and what won’t work, sparing needless complications.

Fact: A dedicated, multidisciplinary Sarcoma Tumor Board meets weekly to evaluate treatment options for every sarcoma patient.

What this means for you: In short, your doctors talk to each other, face-to-face on a weekly basis and plan the right care for you and your specific cancer.

Fact: Siteman Cancer Center has the largest number of sarcoma clinical trials available in the Midwest, with more than 20 active or open clinical trials.

What this means for you: The standard of care at a research hospital is often clinical trials, meaning you get treatments not otherwise available.

Fact: Washington University School of Medicine also is a designated Sarcoma Research Center by the Sarcoma Alliance for Research through Collaboration (SARC) and participates in the NRG Oncology Group, a comprehensive research collaborative.

What this means for you: Promising treatments make it into clinical practice faster and while being treated, you are also helping raise the standard of treatment nationwide.

Fact: Your team includes oncologists, orthopedic surgeons, musculoskeletal radiologists, interventional oncologists and sarcoma pathologists, providing a collective expertise not always available at other cancer centers.

What this means for you: Your specific case is treated individually and not given a standard treatment without consideration of what makes you unique.